Multi-Objective Optimized Fuzzy Logic Control for Robust Automated Insulin Infusion in Type I Diabetes
Raya Abu Shaker, Yousef Sardahi, Ahmad AlshormanType I diabetes mellitus (T1DM) is a chronic metabolic disease resulting from insufficient insulin secretion into the bloodstream‚ causing elevated blood glucose concentrations to dangerous levels․ Automated regulation of blood glucose levels in T1DM can be modeled as a nonlinear‚ uncertain‚ and disturbance-affected closed-loop control process with a time delay‚ time-varying insulin sensitivity, and imperfect glucose measurements. This paper presents the design, multi-objective tuning, and robustness evaluation of a fuzzy logic controller (FLC) for automated insulin-infusion regulation. The proposed FLC uses the glucose tracking error and its time derivative as feedback signals to determine the required insulin control action and maintain glucose within the desired range of (70–160 mg/dL). The controller parameters are optimized using the Non-Dominated Sorting Genetic Algorithm II (NSGA-II) to address three competing control objectives: minimizing hypoglycemia risk, minimizing hyperglycemia risk, and reducing total insulin usage. The resulting Pareto-optimal solutions provide a set of trade-off controller designs for decision-makers based on safety, performance, and insulin-efficiency requirements. The robustness of the proposed automated control framework is evaluated under challenging operating conditions, including elevated initial glucose levels, model-parameter uncertainties, external disturbances, variations in insulin sensitivity, distorted glucose measurements, and delayed insulin infusion. A comparative study with a linear quadratic regulator-based controller (LQRC) is conducted as a benchmark. Simulation results demonstrate that the optimized FLC provides superior closed-loop performance and stronger robustness than the LQRC across all tested scenarios. The proposed fuzzy-control framework, therefore, offers a promising automation-based strategy for resilient glucose regulation under uncertainty, measurement imperfections, and actuation delays.